Your browser doesn't support javascript.
loading
Diagnostic Challenges in Pediatric Hemophagocytic Lymphohistiocytosis.
Si, Stephanie J; Tasian, Sarah K; Bassiri, Hamid; Fisher, Brian T; Atalla, Jasmyn; Patel, Reema; Romberg, Neil; Lambert, Michele P; Paessler, Michele; Behrens, Edward J; Teachey, David T; Sullivan, Kathleen E.
Afiliação
  • Si SJ; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. ssi@cc.hawaii.edu.
  • Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA. ssi@cc.hawaii.edu.
  • Bassiri H; Division of Pediatric Oncology-Hematology, University of Hawai'i Cancer Center, Kapi'olani Medical Center for Women and Children, Honolulu, HI, USA. ssi@cc.hawaii.edu.
  • Fisher BT; University of Hawai'i School of Medicine, 701 Ilalo St, Honolulu, HI, 96813, USA. ssi@cc.hawaii.edu.
  • Atalla J; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Patel R; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Romberg N; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Lambert MP; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Paessler M; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Behrens EJ; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Teachey DT; Department of Internal Medicine and Department of Pediatrics, Vidant Medical Center, East Carolina University, Greenville, NC, USA.
  • Sullivan KE; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
J Clin Immunol ; 41(6): 1213-1218, 2021 08.
Article em En | MEDLINE | ID: mdl-33761058
ABSTRACT
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of severe immune dysregulation that encompasses a broad range of underlying genetic diseases and infectious triggers. Monogenic conditions, autoimmune diseases, and infections can all drive the phenotype of HLH and associated immune hyperactivation with hypercytokinemia. A diagnosis of HLH usually requires a combination of clinical and laboratory findings; there is no single sensitive and specific diagnostic test, which often leads to "diagnostic dilemmas" and delays in treatment initiation. Ferritin levels, one of the most commonly used screening tests, were collected across a large tertiary care pediatric hospital to identify the positive predictive value for HLH. Herein, we present several cases that illustrate the clinical challenges of confirming an HLH diagnosis. Additionally, we report on the utility of establishing a formal multi-disciplinary group to aid the prompt diagnosis and treatment of patients presenting with HLH-like pathophysiologies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfo-Histiocitose Hemofagocítica Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfo-Histiocitose Hemofagocítica Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article